...
首页> 外文期刊>Lipids >Oxidized Low-Density Lipoprotein Inhibits THP-1-Derived Macrophage Autophagy via TET2 Down-regulation
【24h】

Oxidized Low-Density Lipoprotein Inhibits THP-1-Derived Macrophage Autophagy via TET2 Down-regulation

机译:氧化的低密度脂蛋白通过TET2下调抑制THP-1衍生的巨噬细胞自噬。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Oxidized low-density lipoprotein (ox-LDL) is an independent risk factor of atherosclerosis. However, the mechanism underlying its pro-atherosclerosis roles has not yet been well explored. DNA demethylation modification, via DNA methyltransferases or ten-eleven-translocation (TET) family, is a crisis epigenetic regulation for various biological and pathological processes. This study aimed to investigate the effects of ox-LDL on macrophage autophagy and its potential epigenetic mechanism. Results showed that after treatment with 0, 10, 20, 40 or 80 mg/L ox-LDL for 24 h, the autophagy markers Beclin 1 and LC3 expression were obviously decreased at protein levels (P < 0.05). The mRNA and protein expression of TET2 was evidently decreased (P < 0.05). After pre-treatment with TET2 siRNA, the mRNA and protein levels of Beclin 1 and LC3 decreased compared with the 80 mg/L treatment group (P < 0.01). The mRNA and protein levels of Beclin 1 and LC3-II were up-regulated (P < 0.05) in the 5-aza-2'-deoxycytidine (a DNA methyltransferase inhibitor) of pretreatment group. Consistent with the Western blot results, cell immunofluorescence showed that the protein concentration of LC3-II decreased in the TET2 siRNA group and increased in the 5-aza-2'-deoxycytidine group. Taken together, these results showed that DNA demethylation modifications regulate ox-LDL-treated THP-1 macrophages autophagy and TET2 might be a novel regulator.
机译:氧化的低密度脂蛋白(ox-LDL)是动脉粥样硬化的独立危险因素。但是,尚未对其动脉粥样硬化的作用机制进行深入研究。通过DNA甲基转移酶或11-11易位(TET)家族进行的DNA去甲基化修饰是各种生物学和病理学过程的危机表观遗传调控。本研究旨在研究ox-LDL对巨噬细胞自噬的影响及其潜在的表观遗传机制。结果表明,用0、10、20、40或80 mg / L ox-LDL处理24 h后,自噬标记Beclin 1和LC3的表达在蛋白质水平上明显降低(P <0.05)。 TET2的mRNA和蛋白表达明显降低(P <0.05)。用TET2 siRNA进行预处理后,Beclin 1和LC3的mRNA和蛋白水平与80 mg / L治疗组相比有所降低(P <0.01)。预处理组的5-氮杂-2'-脱氧胞苷(一种DNA甲基转移酶抑制剂)中Beclin 1和LC3-II的mRNA和蛋白质水平上调(P <0.05)。与蛋白质印迹结果一致,细胞免疫荧光显示,TET2 siRNA组中LC3-II的蛋白质浓度降低,而5-氮杂2'-脱氧胞苷组中的LC3-II蛋白质浓度升高。两者合计,这些结果表明,DNA去甲基化修饰调节ox-LDL处理的THP-1巨噬细胞自噬,而TET2可能是一种新型调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号